Analysis Article • May 01

Over the last 7 days, the Clinical Research and Equipment industry has dropped 7.0%, driven by AddLife declining 6.2%. The industry has fallen 18% in the last year. As for the next few years, earnings are expected to grow by 17% per annum.
Has the Swedish Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 13 Jul 2026 | SEK 29.6b | SEK 14.6b | -SEK 870,773,579.00 | 34.2x | -33.9x | 2x |
| Wed, 10 Jun 2026 | SEK 29.3b | SEK 14.6b | -SEK 871,304,353.00 | 33.4x | -33.6x | 2x |
| Fri, 08 May 2026 | SEK 28.2b | SEK 14.6b | -SEK 853,896,077.00 | 32.7x | -33.1x | 1.9x |
| Sun, 05 Apr 2026 | SEK 27.4b | SEK 14.6b | -SEK 971,664,077.00 | 32.5x | -28.1x | 1.9x |
| Tue, 03 Mar 2026 | SEK 29.1b | SEK 14.6b | -SEK 838,240,147.00 | 33.6x | -34.7x | 2x |
| Thu, 29 Jan 2026 | SEK 28.4b | SEK 14.9b | -SEK 744,515,427.00 | 43.8x | -38.1x | 1.9x |
| Sat, 27 Dec 2025 | SEK 31.5b | SEK 14.9b | -SEK 744,515,427.00 | 50.2x | -42.4x | 2.1x |
| Mon, 24 Nov 2025 | SEK 33.3b | SEK 14.9b | -SEK 744,515,427.00 | 55.4x | -44.7x | 2.2x |
| Wed, 22 Oct 2025 | SEK 34.6b | SEK 14.7b | SEK 61.3m | 56.9x | 564.4x | 2.4x |
| Fri, 19 Sep 2025 | SEK 36.1b | SEK 14.7b | SEK 61.3m | 61.5x | 589.5x | 2.5x |
| Sun, 17 Aug 2025 | SEK 34.9b | SEK 14.8b | SEK 161.3m | 58.6x | 216.2x | 2.4x |
| Tue, 15 Jul 2025 | SEK 46.7b | SEK 16.6b | SEK 416.3m | 66.9x | 112.3x | 2.8x |
| Thu, 12 Jun 2025 | SEK 47.1b | SEK 16.6b | SEK 404.2m | 70.1x | 116.6x | 2.8x |
| Sat, 10 May 2025 | SEK 46.1b | SEK 16.6b | SEK 420.1m | 44.5x | 109.7x | 2.8x |
| Mon, 07 Apr 2025 | SEK 34.6b | SEK 16.6b | SEK 609.4m | 36.8x | 56.8x | 2.1x |
| Wed, 05 Mar 2025 | SEK 38.9b | SEK 16.6b | SEK 615.4m | 41.4x | 63.2x | 2.3x |
| Fri, 31 Jan 2025 | SEK 39.8b | SEK 16.7b | -SEK 1,152,911,426.00 | 43.5x | -34.5x | 2.4x |
| Sun, 29 Dec 2024 | SEK 44.2b | SEK 16.7b | -SEK 1,152,911,426.00 | 50.9x | -38.3x | 2.6x |
| Tue, 26 Nov 2024 | SEK 42.8b | SEK 16.8b | -SEK 948,723,426.00 | 48.4x | -45.1x | 2.5x |
| Thu, 24 Oct 2024 | SEK 44.1b | SEK 16.7b | -SEK 983,175,491.00 | 77x | -44.9x | 2.6x |
| Sat, 21 Sep 2024 | SEK 47.1b | SEK 16.7b | -SEK 988,175,491.00 | 57.5x | -47.7x | 2.8x |
| Mon, 19 Aug 2024 | SEK 48.2b | SEK 16.7b | -SEK 1,124,972,538.00 | 61.5x | -42.9x | 2.9x |
| Wed, 17 Jul 2024 | SEK 48.2b | SEK 16.5b | -SEK 1,148,686,510.00 | 62.3x | -42x | 2.9x |
| Fri, 14 Jun 2024 | SEK 43.8b | SEK 16.3b | -SEK 1,188,686,510.00 | 59x | -36.9x | 2.7x |
| Sun, 12 May 2024 | SEK 40.3b | SEK 16.3b | -SEK 1,157,635,671.00 | 36.5x | -34.8x | 2.5x |
| Tue, 09 Apr 2024 | SEK 39.7b | SEK 16.0b | -SEK 1,122,792,213.00 | 36.6x | -35.4x | 2.5x |
| Thu, 07 Mar 2024 | SEK 38.0b | SEK 16.0b | -SEK 1,123,139,210.00 | 40.5x | -33.9x | 2.4x |
| Sat, 03 Feb 2024 | SEK 39.0b | SEK 15.8b | -SEK 1,473,823,683.00 | 55.6x | -26.5x | 2.5x |
| Mon, 01 Jan 2024 | SEK 37.7b | SEK 15.5b | -SEK 1,393,723,683.00 | 45.7x | -27x | 2.4x |
| Wed, 29 Nov 2023 | SEK 34.0b | SEK 15.4b | -SEK 1,395,872,683.00 | 39.5x | -24.4x | 2.2x |
| Fri, 27 Oct 2023 | SEK 26.0b | SEK 15.1b | -SEK 1,161,516,711.00 | 32.5x | -22.4x | 1.7x |
| Sun, 24 Sep 2023 | SEK 27.5b | SEK 15.1b | -SEK 1,134,516,711.00 | 38.8x | -24.2x | 1.8x |
| Tue, 22 Aug 2023 | SEK 29.6b | SEK 15.1b | -SEK 213,871,038.00 | 42.4x | -138.4x | 2x |
| Thu, 20 Jul 2023 | SEK 31.7b | SEK 14.9b | -SEK 238,476,038.00 | 41.6x | -132.9x | 2.1x |
-132.9x
How does Swedish Clinical Research and Equipment compare with similar industries?
| SE Market | -1.78% | |
| Healthcare | -2.49% | |
| Life Sciences | -6.96% | |
| Clinical Research and Equipment | -6.96% | |
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| PRO Promimic | SEK 10.30 | 3.0% +SEK 5.7m | -42.0% | PS3.9x | |
| LEVBIO Level Bio | SEK 0.28 | 12.7% +SEK 2.2m | 0% | PS0.6x | |
| IDLDX IDL Diagnostics | SEK 0.42 | 2.0% +SEK 1.8m | -18.8% | PS1.8x | |
| MAGLE Magle Chemoswed Holding | SEK 1.01 | 1.0% +SEK 282.0k | -96.1% | PS0.1x |